PhaseBio Pharmaceuticals, Inc. (PHAS)
Net Change in Cash
-$56.65M
TTM · Period ending: · USD
PHAS Net Change in Cash
Latest reported-$56.65Mperiod ending
Latest reported-$56.65Mperiod ending
PHAS TTM Net Change in Cash ($2.23M → -$56.65M)
TTM net change in cash
High-resolution chart · PNG
PHAS net change in cash history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Net Change in Cash (USD) |
|---|---|
| -56,652,000 | |
| -58,275,000 | |
| 13,678,000 | |
| 17,004,000 | |
| 11,431,000 | |
| 17,522,000 | |
| -45,903,000 | |
| -42,418,000 | |
| -37,317,000 | |
| 7,527,000 | |
| 12,974,000 | |
| 57,430,000 | |
| 81,608,000 | |
| 41,148,000 | |
| 47,645,000 | |
| 20,064,000 | |
| 2,230,000 |